Reed E - Search Results

1

A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer.

Senderowicz AM, Reid R, Headlee D, Abornathy T, Horti J, Lush RM, Reed E, Figg WD, Sausville EA. Senderowicz AM, et al. Among authors: reed e. Urol Int. 1999;63(2):120-5. doi: 10.1159/000030430. Urol Int. 1999. PMID: 10592501 Clinical Trial.

2

Acute renal toxicity associated with suramin in the treatment of prostate cancer.

Figg WD, Cooper MR, Thibault A, Headlee D, Humphrey J, Bergan RC, Reed E, Sartor O. Figg WD, et al. Among authors: reed e. Cancer. 1994 Sep 1;74(5):1612-4. doi: 10.1002/1097-0142(19940901)74:5<1612::aid-cncr2820740519>3.0.co;2-q. Cancer. 1994. PMID: 8062193

3

Treatment approaches for metastatic cancer of the prostate based on recent molecular evidence.

Middleman MN, Lush RM, Sartor O, Reed E, Figg WD. Middleman MN, et al. Among authors: reed e. Cancer Treat Rev. 1996 Mar;22(2):105-18. doi: 10.1016/s0305-7372(96)90030-4. Cancer Treat Rev. 1996. PMID: 8665563 Review. No abstract available.

4

A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response.

Bowden CJ, Figg WD, Dawson NA, Sartor O, Bitton RJ, Weinberger MS, Headlee D, Reed E, Myers CE, Cooper MR. Bowden CJ, et al. Among authors: reed e. Cancer Chemother Pharmacol. 1996;39(1-2):1-8. doi: 10.1007/s002800050531. Cancer Chemother Pharmacol. 1996. PMID: 8995493 Clinical Trial.

5

A phase I study of pentosan polysulfate sodium in patients with advanced malignancies.

Lush RM, Figg WD, Pluda JM, Bitton R, Headlee D, Kohler D, Reed E, Sartor O, Cooper MR. Lush RM, et al. Among authors: reed e. Ann Oncol. 1996 Nov;7(9):939-44. doi: 10.1093/oxfordjournals.annonc.a010797. Ann Oncol. 1996. PMID: 9006745 Free article. Clinical Trial.

6

In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3.

Dixon SC, Zalles A, Giordano C, Lush RM, Venzon D, Reed E, Figg WD. Dixon SC, et al. Among authors: reed e. Cancer Lett. 1997 Feb 26;113(1-2):111-6. doi: 10.1016/s0304-3835(97)04603-x. Cancer Lett. 1997. PMID: 9065809

7

Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.

Dawson NA, Figg WD, Cooper MR, Sartor O, Bergan RC, Senderowicz AM, Steinberg SM, Tompkins A, Weinberger B, Sausville EA, Reed E, Myers CE. Dawson NA, et al. Among authors: reed e. J Clin Oncol. 1997 Apr;15(4):1470-7. doi: 10.1200/JCO.1997.15.4.1470. J Clin Oncol. 1997. PMID: 9193342 Clinical Trial.

8

Bergan RC, Walls RG, Figg WD, Dawson NA, Headlee D, Tompkins A, Steinberg SM, Reed E. Bergan RC, et al. Among authors: reed e. J Natl Med Assoc. 1997 Sep;89(9):622-8. J Natl Med Assoc. 1997. PMID: 9302860 Free PMC article.

9

Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.

Dawson N, Figg WD, Brawley OW, Bergan R, Cooper MR, Senderowicz A, Headlee D, Steinberg SM, Sutherland M, Patronas N, Sausville E, Linehan WM, Reed E, Sartor O. Dawson N, et al. Among authors: reed e. Clin Cancer Res. 1998 Jan;4(1):37-44. Clin Cancer Res. 1998. PMID: 9516950 Clinical Trial.

10

A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer.

Thibault A, Figg WD, Bergan RC, Lush RM, Myers CE, Tompkins A, Reed E, Samid D. Thibault A, et al. Among authors: reed e. Tumori. 1998 Jan-Feb;84(1):87-9. doi: 10.1177/030089169808400120. Tumori. 1998. PMID: 9619724 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,330 results

Search Page

Filters